Hyperthyroidism is a common condition with a global prevalence of 0· 2–1· 3%. When
clinical suspicion of hyperthyroidism arises, it should be confirmed by biochemical tests (eg …

Whether or not Graves' hyperthyroidism can be really cured, depends on the definition of
“cure.” If eradication of thyroid hormone excess suffices for the label “cure,” then all patients …

Introduction Graves' disease (GD) is an autoimmune disorder due to loss of tolerance to the
thyrotropin receptor (TSHR) and ultimately caused by stimulatory TSHR antibodies (TSHR …

Antithyroid drugs (ATD) are the treatment of choice for the majority of patients with Graves'
hyperthyroidism worldwide. However, relapse of hyperthyroidism after withdrawal of …

Thyroid-associated orbitopathy, the most common extrathyroidal manifestation of Graves'
disease, is characterized by orbital inflammatory infiltration and activation of orbital …

Abstract Background Antithyroid drugs (ATDs) are first-line treatment for Graves'
hyperthyroidism worldwide, but relapses are frequent. The reliability of individual risk factors …

Abstract Purpose Antithyroid drugs (ATDs) are the first-line treatment for Graves' disease
(GD). A common problem with ATD treatment is the high relapse rate after drug withdrawal …

Since there have been few reports on the long-term prognosis of Graves' hyperthyroidism,
the prognosis of 549 Graves' hyperthyroidism patients initially treated with thionamide and …

Introduction Graves' disease (GD) is an autoimmune disorder characterized by
hyperthyroidism due to increased thyroid-stimulating hormone receptor antibodies (TRAb) …

Background Graves' disease (GD) is caused by the production of TSH-receptor (TSHR)
stimulating auto-antibodies. Over the years various TSHR-antibody (TRAb) detection assays …